Tags
Center for Devices and Radiological Health, Defibrillation, FDA, Food & Drug Administration, Hip Replacement, Medical device, ProPublica, UNited States
Governmental Oversight of Potentially Dangerous Medical Devices – US Politics Today.
Governmental Oversight of Potentially Dangerous Medical Devices
Public and scientific criticism is growing that governmental oversight of medical devices being implanted in Americans is insufficient, often allowing downright dangerous devices to harm patients.
July 07, 2012 /24-7PressRelease/ — Public and scientific criticism is growing that governmental oversight of medical devices being implanted in Americans is insufficient, often allowing downright dangerous devices to harm patients. Medical-device safety is imperative because some like defibrillators, pacemakers and heart valve rings are literally life sustaining.
Even if a device does not directly prolong life, if it does not safely, reliably and effectively perform its intended function, a patient may be catastrophically injured, sometimes permanently. Recent controversial medical devices known to have caused harm to patients after reaching the market include:
- Surgical mesh that can puncture organ walls
- Artificial hips that shed metal particles into surrounding tissues
- Heart-defibrillator wires that short out
The Food and Drug Administration is the federal agency responsible for seeing that medical products such as devices, medications and dietary supplements (among other things) marketed for use in patients are safe. Within the FDA, the Center for Devices and Radiological Health, known as the CDRH, specifically oversees medical devices.
Current FDA procedures have been criticized for allowing new devices to be sold before sufficient pre-market testing is done to determine whether devices are truly ready for safe use. Normally, most devices must conform to stringent pre-market testing and receive FDA approval before they are allowed to be sold.
However, if a manufacturer can show the agency that a device is “substantially equivalent” to one already on the market, the device can be released for sale without the same rigor. Allowing an equivalent product to market without the usual amount of testing and data is referred to as a “501(k) approval.”
The 501(k) process is meant for less risky devices, but, reportedly, the question of what is a risky device can be problematic, allowing more serious devices to receive 501(K) status. For example, ProPublica recently reported in a major investigation that the heart valve ring industry asked the FDA to reclassify the rings to a lower risk level that would allow 501(K) equivalency approval without rigorous pre-market review, and the FDA did so.
After a medical device is on the market, and it becomes apparent that the device violates federal consumer safety law by being either defective or a health risk, the responsible private party (like the distributor or manufacturer) usually voluntarily recalls the device. The FDA also has the power to force a responsible company to recall a dangerous device, although FDA-initiated recalls are reportedly not common.
A recall can mean several things. The device may have to be removed from the patient’s body, but it could mean instead that the device needs to be checked, fixed or monitored.
In addition to the recall decision, when a product is released without sufficient pre-market evaluation and reports of injury surface later, the FDA may require manufacturers to do testing, or the agency itself may conduct studies and gather evidence, and determine whether warnings must be issued to consumers or medical professionals.
Medical facilities are supposed to report device problems to the FDA, and manufacturers are to inform the agency when they take affirmative actions to protect patient health in response to device concerns. The FDA also has the power to fine manufacturers for certain device safety violations.
A recent New England Journal of Medicine article called for the U.S. to require a national registry for each high-risk medical device in use, a common requirement in other countries. Each time the device is implanted by a medical provider the surgery and later postoperative outcomes are recorded in the registry. Some U.S. providers are voluntarily using such registries already.
While Americans wait for stricter federal laws and regulations to be implemented, citizens may be wary of medical-device reliability. Ask your doctor probing questions; get a second opinion; and do outside research.
If you or a loved one is injured by a defective medical device, you may have legal remedies like lawsuits for personal injury, product liability or medical malpractice. If a loved one has died from complications from a dangerous medical device, you may have grounds for a wrongful death suit. Talk to an experienced medical device attorney to learn about your options and rights.
Article provided by Apffel Law Firm
Visit us at www.apffellaw.com
Related articles
- New FDA guidance on considerations used in device approval (earlsview.com)
- Medical Device ” The Senate Passes Unparalleled Medical Device User Fee Act (earlsview.com)
- Post-Approval Studies for Smith & Nephew BHR – NOT USEFUL (earlsview.com)
- Rottenstein Law Group Encouraged by FDA’s Proposed Rule Establishing a Unique Device Identification System (prweb.com)
- Rottenstein Law Group Applauds FDA Device Chief’s Recommendation To Close Dangerous Loophole In Agency’s Medical-Device Approval Process (prweb.com)
- The Senate Passes Unparalleled Medical Device User Fee Act (depuyrecall.wordpress.com)
- FDA proposes new device ID system to boost recall efforts, and patient safety (medcitynews.com)
- Consumers Union Urges Congress to Adopt Stronger Medical Device Patient Safety (clarksvilleonline.com)
- FDA Proposes IDs To Track Medical Device Safety (huffingtonpost.com)
- Tell Congress to fix … The medical-device safety bill (point4counterpoint.wordpress.com)
Pingback: MoMs Hips a Grinding Dilemma for Hospitals, Doctors, FDA « Earl's View
Pingback: FDA Proposes New Rule That Would Require Medical Devices Such as Surgical Mesh to Carry Unique Device Identifier « Earl's View
Pingback: FDA Faces Daunting Task as Health Apps Multiply | Sci-Tech Today « Earl's View
Pingback: FDA – User Fees for Medical Devices: Third Time Lucky? « Earl's View
Pingback: FDA to guide device makers on marketing application – chicagotribune.com « Earl's View
Pingback: Press Announcements > FDA outlines plans to provide earlier feedback on device product submissions « Earl's View
Pingback: FDA to help medical device sales with expanded pre-market feedback program « Earl's View
Pingback: Henry Miller: FDA has device makers looking outside U.S. | fda, device, medical – Opinion – The Orange County Register « Earl's View
Pingback: Is the US Medical Device Industry Heading the Way of the Dinosaur? « Earl's View
Pingback: The US Medical Device Market is a Dinosaur – Mike comments « Earl's View
Pingback: Loophole in FDA’s Approval Process for Medical Devices Prompts Letter from Congress – Forbes « Earl's View
Pingback: » Medical device units recalled in Q2 represent eight-quarter high | MedCity News « Earl's View